Overview

J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this post marketing survey is to prospectively investigate patients with hypertension treated with Micardis Tablets (hereinafter "this drug") in routine clinical settings for 3 years in order to determine the following: 1. Adverse events and adverse drug reactions under long-term use 2. Blood pressure measurements during the survey period 3. Determination of the incidence of cerebrovascular and cardiovascular events under use of this drug in routine clinical settings 4. Patient's lifestyle and background factors that are considered to affect the occurrence of cerebrovascular and cardiovascular events
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Telmisartan